课题基金 / 基金详情

Phase Two of the Canadian Consortium on Neurodegeneration in Aging

Phase Two of the Canadian Consortium on Neurodegeneration in Aging
加拿大老龄化神经退行性疾病联盟第二阶段
批准号：
399820
负责人：
Chertkow Howard M
金额：
$2303.88万
依托单位：
Rotman Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Miscellaneous Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-01-01 至 2024-01-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=399820&lang=en
关键词：
Alzheimer Disease Dementia Diagnosis Prevention Quality Of Life Sex Treatment

项目摘要

项目成果

Chertkow Howard M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Canadian Consortium for Neurodegeneration and Aging (CCNA) is an important response to the urgent health problem of Alzheimer Disease (AD) and other more rare dementias-together termed the neurodegenerative diseases (NDD)- in Canada. Our mission is to
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canadian Consortium on Neurodegeneration in Aging: Application for Phase III CCNA Operations Centre
Broad and Deep Analyses in Neurodegeneration (BRAIN)
Typical and atypical Alzheimer Disease: salivary tau biomarkers, therapy with neuromodulation, and disease subtypes.
Canadian Consortium on Neurodegeneration in Aging
海外基金